Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.92K | 0 | 0 | -95.73%12.2K | -58.56%1.08K | 0 | -97.54%3.1K | -94.22%8.02K | -50.84%285.59K | -99.04%2.61K |
| Operating revenue | --5.92K | --0 | --0 | -95.73%12.2K | -58.56%1.08K | --0 | -97.54%3.1K | -94.22%8.02K | -50.84%285.59K | -99.04%2.61K |
| Cost of revenue | 1.93K | 0 | 0 | -98.34%5.3K | -105.38%-2.4K | 0 | -99.38%768 | -94.79%6.92K | -41.05%318.38K | -82.95%44.56K |
| Gross profit | 3.98K | 0 | 0 | 121.06%6.91K | 108.28%3.48K | 0 | 18.17%2.34K | -81.27%1.1K | -180.23%-32.79K | -475.67%-41.95K |
| Operating expense | 854.78%668.38K | 27.02%266.62K | -6.25%198.33K | -41.25%927.61K | 18.67%436.17K | -71.61%70K | -64.63%209.9K | -43.01%211.55K | 67.93%1.58M | 5.12%367.55K |
| Selling and administrative expenses | 795.12%623.49K | 27.15%266.62K | -6.15%198.33K | -42.77%901.18K | 11.75%410.5K | -71.73%69.65K | -64.66%209.69K | -42.52%211.34K | 75.11%1.57M | 18.73%367.34K |
| -Selling and marketing expense | 2,796.28%144.81K | -83.93%1.98K | --0 | -89.13%41.42K | -111.57%-6.92K | -84.97%5K | -81.05%12.3K | -86.09%31.04K | 39.74%381.03K | -76.30%59.78K |
| -General and administrative expense | 640.36%478.67K | 34.07%264.64K | 10.00%198.33K | -27.97%859.76K | 35.72%417.42K | -69.66%64.65K | -62.64%197.39K | 24.73%180.31K | 90.50%1.19M | 438.57%307.56K |
| Research and development costs | ---- | ---- | --0 | --26K | ---- | ---- | ---- | --0 | --0 | ---- |
| Depreciation amortization depletion | 12,762.18%44.89K | --0 | --0 | -89.63%431 | -260.39%-332 | 68.60%349 | 0.00%207 | -94.15%207 | -89.83%4.16K | -99.49%207 |
| -Depreciation and amortization | 12,762.18%44.89K | --0 | --0 | -89.63%431 | -260.39%-332 | 68.60%349 | 0.00%207 | -94.15%207 | -89.83%4.16K | -99.49%207 |
| Operating profit | -849.10%-664.4K | -28.45%-266.62K | 5.76%-198.33K | 42.87%-920.71K | -5.66%-432.69K | 71.45%-70K | 64.91%-207.56K | 42.40%-210.45K | -79.21%-1.61M | -20.98%-409.5K |
| Net non-operating interest income (expenses) | 592 | |||||||||
| Non-operating interest income | --592 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 21.12%-49.11K | -126.71%-110.39K | -10.86%-49.07K | -797.05%-62.26K | -69.07%947 | 78.70%-48.69K | 48.39%-44.26K | |||
| Gain on sale of security | ---- | -2,380.45%-49.11K | ---- | 100.42%37 | 99.59%-18 | ---- | 71.47%-1.98K | -33.54%2.04K | -45.13%-8.8K | ---4.37K |
| Special income (charges) | --0 | ---- | --0 | -176.78%-110.42K | -22.95%-49.05K | --0 | ---60.28K | ---1.09K | 82.07%-39.9K | 49.94%-39.9K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 43.57%11.77K | ---- | ---- | ---- | ---- | -77.22%8.2K | ---- |
| -Less:Write off | --0 | ---- | --0 | 211.24%98.65K | 17.61%37.28K | --0 | --60.28K | --1.09K | --31.7K | --31.7K |
| Income before tax | -848.25%-663.8K | -17.01%-315.73K | 5.33%-198.33K | 37.90%-1.03M | -6.17%-481.76K | 71.52%-70K | 54.91%-269.83K | 42.17%-209.51K | -47.21%-1.66M | -6.96%-453.76K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -848.25%-663.8K | -17.01%-315.73K | 5.33%-198.33K | 37.90%-1.03M | -6.17%-481.76K | 71.52%-70K | 54.91%-269.83K | 42.17%-209.51K | -47.21%-1.66M | -6.96%-453.76K |
| Net income continuous operations | -848.25%-663.8K | -17.01%-315.73K | 5.33%-198.33K | 37.90%-1.03M | -6.17%-481.76K | 71.52%-70K | 54.91%-269.83K | 42.17%-209.51K | -47.21%-1.66M | -6.96%-453.76K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -845.43%-661.83K | -17.01%-315.73K | 5.33%-198.33K | 37.90%-1.03M | -6.17%-481.76K | 71.52%-70K | 54.91%-269.83K | 42.17%-209.51K | -47.21%-1.66M | -6.96%-453.76K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -845.43%-661.83K | -17.01%-315.73K | 5.33%-198.33K | 37.90%-1.03M | -6.17%-481.76K | 71.52%-70K | 54.91%-269.83K | 42.17%-209.51K | -47.21%-1.66M | -6.96%-453.76K |
| Diluted earnings per share | -100.00%-0.02 | 50.00%-0.02 | 0.00%-0.03 | 48.28%-0.15 | -40.01%-0.07 | 83.33%-0.01 | 66.67%-0.04 | 50.00%-0.03 | -20.83%-0.29 | 16.67%-0.05 |
| Basic earnings per share | -100.00%-0.02 | 50.00%-0.02 | 0.00%-0.03 | 48.28%-0.15 | -40.01%-0.07 | 83.33%-0.01 | 66.67%-0.04 | 50.00%-0.03 | -20.83%-0.29 | 16.67%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.